Vancouver, British Columbia – October 16, 2025 – TheNewswire - MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) announces that the transaction agreements entered into on October 16, 2023 between the Company, Mentorhead Incorporation dba Limmi (“Limmi”) and certain subsidiaries of the Company have been terminated upon mutual agreement of the parties. Please refer to the Company’s news release dated October 17, 2023, for details of the agreements which have been terminated.

Pursuant to the termination agreement, the parties have agreed that (i) all equity interests in Limmi issued to the Company pursuant to the transaction agreements will be returned and cancelled; and (ii) all common shares in the Company’s subsidiary, Vinergy Acquisition Corp., issued to Limmi pursuant to the transaction agreements will be returned and cancelled. As a result, Limmi will no longer be entitled to exchange such shares into up to 35,000,000 Class A non-voting common shares (which are convertible on a one-for-one basis into common shares of the Company) upon the satisfaction of certain conditions set out in the transaction agreements.

About MedBright AI Investments Inc.

MedBright AI Investments Inc. is a capital allocator focused on investing in diversified industries, with a primary focus on technology and artificial intelligence. These include both public and private companies. Medbright has a focus on near-term and mid-term high quality opportunities with strong return potential while maintaining its commitment to governance.

For further information, please contact:

MedBright AI Investments Inc.
Geoff Balderson, CFO
Email: gb@corporateminds.ca
Phone: (604) 602-0001
www.medbrightai.ca

Copyright (c) 2025 TheNewswire - All rights reserved.